{"postfix": "vertex_pharmaceuticals-aktie", "name": "VERTEX_PHARMACEUTICALS", "wkn": "882807", "time": "2020.06.02 12:46", "ts": 1591094771, "features": {"KGV": "41.41", "Marktkapitalisierung": {"Size": "Mrd", "Value": "64.61"}, "GA": "5.33", "KBV": "9.38", "BA": "23.53", "KCV": "34.22", "CA": "6.45", "Vola30": "54.32", "Vola90": "61.92", "Vola180": "48.35", "Vola250": "39.34"}, "rivals": ["merck_co-aktie", "bayer-aktie", "novartis-aktie", "pfizer-aktie", "bristol-myers_squibb-aktie", "abbott_laboratories-aktie", "astrazeneca-aktie"], "text_data": {"de": [["31.05.20", "Mai 2020: So haben Analysten ihre Einstufung der Vertex Pharmaceuticals-Aktie angepasst"], ["01.05.20", "Vertex Pharmaceuticals: So viel setzte das Unternehmen zuletzt um"], ["30.04.20", "So sch\u00e4tzen die Analysten die Zukunft der Vertex Pharmaceuticals-Aktie ein"], ["28.04.20", "Ausblick: Vertex Pharmaceuticals pr\u00e4sentiert Bilanzzahlen zum j\u00fcngsten Jahresviertel"], ["03.02.20", "Vertex Pharmaceuticals hat die Zahlen zum j\u00fcngsten Quartal vorgelegt"], ["29.01.20", "Ausblick: Vertex Pharmaceuticals gew\u00e4hrt Anlegern Blick in die B\u00fccher"]], "en": [["28.05.20", "Zacks.com featured highlights include: BJs Wholesale Club, Fortinet, Vertex Pharmaceuticals, SPS Commerce and Repligen"], ["27.05.20", "Has Vertex Pharmaceuticals (VRTX) Outpaced Other Medical Stocks This Year?"], ["24.05.20", "Is Vertex Pharmaceuticals Stock a Buy?"], ["20.05.20", "The Zacks Analyst Blog Highlights: Chegg, Quidel, MarketAxess, Dropbox and Vertex Pharmaceuticals"], ["20.05.20", "The Zacks Analyst Blog Highlights: Chegg, Nautilus Group, Sprouts Farmers Market, VeriSign and Vertex Pharmaceuticals"], ["19.05.20", "The Zacks Analyst Blog Highlights: The Hain Celestial Group, Murphy USA, Vertex Pharmaceuticals, Sprouts Farmers Market and ASE Technology"], ["19.05.20", "Vertex Pharmaceuticals, Align Technology, Walmart, Home Depot and Target highlighted as Zacks Bull and Bear of the Day"], ["18.05.20", "Surging Earnings Estimates Signal Good News for Vertex Pharmaceuticals (VRTX)"], ["11.05.20", "Has Vertex Pharmaceuticals (VRTX) Outpaced Other Medical Stocks This Year?"], ["08.05.20", "Zacks.com featured highlights include: Logitech International, MACOM Technology Solutions, Murphy USA, Vertex Pharmaceuticals and The Clorox Company"], ["08.05.20", "3 Reasons to Buy Vertex Pharmaceuticals Stock Right Now"], ["07.05.20", "Zacks.com featured highlights include: Activision Blizzard, Guardant Health, Vertex Pharmaceuticals, Aphria and Shopify"], ["06.05.20", "Zacks.com featured highlights include: Vertex Pharmaceuticals, Alibaba, Amedisys and Fabrinet"], ["06.05.20", "Zacks.com featured highlights include: Cogent Communications, Murphy USA, Vertex Pharmaceuticals and B2Gold"], ["02.05.20", "Better Buy: Vertex Pharmaceuticals vs. Alexion Pharmaceuticals"], ["30.04.20", "Vertex Pharmaceuticals Inc (VRTX) Q1 2020 Earnings Call Transcript"], ["29.04.20", "Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Beat Estimates"], ["29.04.20", "The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Sprouts Farmers Market, The Hain Celestial, Virtu Financial and Pixelworks"], ["28.04.20", "Why Vertex Pharmaceuticals (VRTX) Might Surprise This Earnings Season"], ["24.04.20", "Has Vertex Pharmaceuticals (VRTX) Outpaced Other Medical Stocks This Year?"], ["22.04.20", "Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth"], ["10.04.20", "Where Will Vertex Pharmaceuticals Be in 1 Year?"], ["09.04.20", "Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know"], ["06.04.20", "The Zacks Analyst Blog Highlights: Amazon, Medtronic, Vertex Pharmaceuticals, Intuit and Bayer"], ["03.04.20", "Vertex Pharmaceuticals (VRTX) Dips More Than Broader Markets: What You Should Know"], ["01.04.20", "Better Buy: Vertex Pharmaceuticals vs. Regeneron Pharmaceuticals"], ["31.03.20", "Is Vertex Pharmaceuticals (VRTX) Outperforming Other Medical Stocks This Year?"], ["27.03.20", "Vertex Pharmaceuticals to Pause Some Clinical Trials"], ["18.03.20", "Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know"], ["17.03.20", "Why Biogen, GW Pharmaceuticals, and Vertex Pharmaceuticals Stocks Jumped Today"], ["17.03.20", "Zacks.com featured highlights include: Fabrinet, Lumentum, Daqo New Energy and Vertex Pharmaceuticals"], ["17.03.20", "The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Co-Diagnostics, Moderna and Vertex Pharmaceuticals"], ["12.03.20", "Has Vertex Pharmaceuticals (VRTX) Outpaced Other Medical Stocks This Year?"], ["25.02.20", "Has Vertex Pharmaceuticals (VRTX) Outpaced Other Medical Stocks This Year?"], ["21.02.20", "Jim Cramer: Experts are calling Vertex Pharmaceuticals the 'most promising story in biotech'"], ["20.02.20", "Surging Earnings Estimates Signal Good News for Vertex Pharmaceuticals (VRTX)"], ["19.02.20", "Better Buy: Vertex Pharmaceuticals vs. Incyte"], ["12.02.20", "Zacks.com featured highlights include: Chipotle Mexican Grill, Vertex Pharmaceuticals, ResMed, Spirit Airlines and OneMain"], ["05.02.20", "Is Vertex Pharmaceuticals (VRTX) Stock Outpacing Its Medical Peers This Year?"], ["02.02.20", "Where Will Vertex Pharmaceuticals Be in 10 Years?"], ["2020-05-29 15:31", "Why Is Vertex (VRTX) Up 10.4% Since Last Earnings Report? ...  A. If you aren't focused on one strategy, this score is the one you should be interested in. Outlook Estimates have been trending upward for the stock, and the magnitude of these revisions looks promising. It comes with little surprise Vertex has a Zacks Rank #1 (Strong Buy). We expect an above average return from the stock in the next few months. In-Depth Zacks Research for the Tickers Above Normally $25 each - click below to receive one report FREE: Vertex Pharmaceuticals Incorporated (VRTX) - free report > > Published in earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate Zacks' 7 Best Strong Buy Stocks for June, 2020 Free Research for Zacks.com Readers Experts have chosen 7 stocks out ... "], ["2020-05-29 11:03", "Got $3,000? Here Are 3 Great Biotech Stocks to Buy Right Now ...  of success for AXS-14 and AXS-12 (which is set to begin late-stage testing in treating narcolepsy later this year) makes Axsome even more attractive. Motley Fool Returns Stock Advisor S&P 500 413% 90% Stock Advisor launched in February of 2002. Returns as of 05/29/2020. Join Stock Advisor Cumulative Growth of a $10,000 Investment in Stock Advisor Calculated by Time-Weighted Return Stocks IONS Ionis Pharmaceuticals NASDAQ: IONS $56.44 up $0.32 (0.57%) VRTX Vertex Pharmaceuticals NASDAQ: VRTX $277.38 down $-1.13 (-0.41%) AXSM Axsome Therapeutics NASDAQ: AXSM $76.52 down $-1.93 (-2.46%) PFE Pfizer NYSE: PFE $38.18 up $0.77 (2.06%) RHHBY Roche Holding Ltd. (ADR) OTC: RHHBY $43.95 up $0.85 (1.97%) BIIB Biogen NASDAQ: BIIB $300.50 down $0.96 (-0.32%) ALNY Alnylam ... "], ["2020-05-28 17:36", "IBD Live Q&A Summary, Key Lists For Thursday, May 28, 2020 ...  Diabetes Care Inc TPTX Turning Point Therap TREX Trex Company Inc TSCO Tractor Supply Co TSLA Tesla Inc TTD The Trade Desk Inc Cl A TW Tradeweb Markets Cl A TWLO Twilio Inc Cl A TXG 10x Genomics Inc Cl A TYL Tyler Technologies Inc UNH Unitedhealth Group Inc UNP Union Pacific Corp V Visa Inc Cl A VEEV Veeva Systems Inc Cl A VRSK Verisk Analytics Inc VRTX Vertex Pharmaceuticals WDAY Workday Inc Cl A WING Wingstop Inc WIX Wix.com Ltd WORK Slack Technologies Cl A WST West Pharmaceutical Svcs Z Zillow Group Inc Cl C ZEN Zendesk Inc ZM Zoom Video Comm Cl A Top Mutual Funds For Your Stock Research Symbol Name ALSAX ALGER SMALL CAP GROWTH A ACRNX Columbia Acorn Inst FCNTX Fidelity Contrafund FMAGX Fidelity Magellan FOCPX Fidelity OTC FKGRX Franklin Growth A VGRAX ... "], ["2020-05-28 16:29", "Despite Coronavirus, These 22 Fastest-Growing Companies Expect 25%-150% Growth In 2020 ... PLMR ) and Tradeweb Markets ( TW ) have also made various IBD growth screens. Fastest-Growing Companies In 2020 Company Symbol EPS Est Cur Yr % EPS Rating RS Rating SMR Rating Comp Rating ROE Pre-tax Margin GSX Techedu GSX 150 84 97 A 96 54.5 14.3 Quidel QDEL 126 97 99 A 99 26 27.1 Pennymac Financial Svcs PFSI 87 97 88 A 96 21.2 31.3 Inphi IPHI 65 82 98 A 98 21.5 21.7 SSR Mining SSRM 65 88 91 A 97 9.5 21.6 Vertex Pharmaceuticals VRTX 65 99 94 A 99 26.4 42.9 Advanced Micro Devices AMD 59 99 95 A 99 36.9 11.6 Netflix NFLX 56 99 91 A 98 29.1 10.2 Dropbox DBX 46 80 88 A 99 27.9 13.8 Zynex ZYXI 43 95 98 A 99 65.2 26.3 Nvidia NVDA 37 99 97 A 99 33.2 35.4 Cabot Microelectronics CCMP 34 89 89 A 96 17.9 19.4 MarketAxess Holdings MKTX 32 95 93 A 97 29.7 50.3 Bristol ... "], ["2020-05-28 15:41", "MORGAN STANLEY: Buy these 23 high-growth stocks that look poised to deliver market-beating returns over the long term ... .1% Source: Morgan Stanley Research ModelWare, Thomson Reuters. 14. NVIDIA NVDA Ticker: NVDA Stock rating: Overweight Revenue CAGR % 2019-2022 estimate: 17.1% Source: Morgan Stanley Research ModelWare, Thomson Reuters. 13. Netflix NFLX Ticker: NFLX Stock rating: Overweight Revenue CAGR % 2019-2022 estimate: 17.6% Source: Morgan Stanley Research ModelWare, Thomson Reuters. 12. Vertex Pharmaceuticals VRTX Ticker: VRTX Stock rating: Overweight Revenue CAGR % 2019-2022 estimate: 19.4% Source: Morgan Stanley Research ModelWare, Thomson Reuters. 11. Amazon AMZN Ticker: AMZN Stock rating: Overweight Revenue CAGR % 2019-2022 estimate: 19.4% Source: Morgan Stanley Research ModelWare, Thomson Reuters. 10. Insulet PODD Ticker: PODD Stock rating: Overweight Revenue CAGR ... "], ["2020-05-28 15:34", "Zacks.com featured highlights include: BJs Wholesale Club, Fortinet, Vertex Pharmaceuticals, SPS Commerce and RepligenZacks.com featured highlights include: BJs Wholesale Club, Fortinet, Vertex Pharmaceuticals, SPS Commerce and Repligen"], ["2020-05-28 10:00", "Long Island's 2010 valedictorians: 10 years later ... pandemic. We signed up to take care of people. We signed up to be doctors,\" Liang said. Christopher Gerry, left, in 2010, and right, in 2020. Christopher Gerry High school: Portledge School College: Amherst College, Class of 2014 Today: Fellow at Vertex Pharmaceuticals Lives in: Somerville, Mass. The next time you take a pill, Christopher Gerry might have had something to do with it. Gerry, one of Portledge School's two valedictorians for 2014, is a part of a one-year fellowship program at Vertex Pharmaceuticals, helping to create new medicine. While his company doesn't work with infectious diseases, he said they do make medicines for cystic fibrosis. \"We have focused all of our efforts to make sure our patients have access to the medications ... "], ["2020-05-28 09:32", "MRNA Moderna using unethical and untested animal and human genes in vaccine - social media bans info ...  well. They founded Moderna (MRNA) with guess who: Moderna is creating potential mRNA medicines for a wide range of diseases and conditions which currently include infectious diseases, oncology, rare genetic diseases, and cardiovascular diseases. Moderna is developing these potential medicines independently and through strategic alliances with collaborators, including AstraZeneca, Merck, and Vertex Pharmaceuticals, as well as the Defense Advanced Research Projects Agency (DARPA) , the Biomedical Advanced Research and Development Authority (BARDA), and the Bill & Melinda Gates Foundation. This is not the first report of social media banning/censorship starting with ZeroHedge being banned from Twitter or Alex Jones being banned from YouTube. The scary question ... "], ["2020-05-27 21:48", "Dow Jones Futures: Vertex, Netflix, Workday Lead Bullish Rebounds In Coronavirus Market Rally; Boeing 737 Max Production Resumes ...  05/27/2020 Dow Jones futures tilted higher late Wednesday, along with S&P 500 futures and Nasdaq futures, as Boeing ( BA ) resumed 737 Max production. The coronavirus stock market rally powered ahead Wednesday, with real world sectors such as airlines, retailers and banks outperforming for a second day. X The Nasdaq rebounded for solid gains while Vertex Pharmaceuticals ( VRTX ), Netflix ( NFLX ), Google parent Alphabet ( GOOGL ), Microsoft ( MSFT ), Tesla ( TSLA ), ServiceNow ( NOW ) and Regeneron ( REGN ) staged bullish reversals. Boeing 737 Max Production Resumes Boeing 737 Max production has resumed, though the ailing jet is still grounded. The Dow Jones aerospace giant halted 737 Max production in late January, as orders plunged. Air travel has plunged ... "], ["2020-05-27 19:45", "Dow Jones Surges 1,052 Points In 2 Days, Small Caps Lead; Sell These Growth Stocks Or Buy? ...  run in recent weeks, but on Wednesday West Texas intermediate near-term futures dropped more than 4% to $32.83 a barrel. Gold fell just 0.1% to trade around 5% below a 52-week peak of $1,789 an ounce. Beyond Dow Jones: Growth Stocks Make This Key Chart Test Meanwhile, top-rated companies in various IBD stock lists for excellent stocks showed some bullish reversals. Vertex Pharmaceuticals ( VRTX ) fell all the way down to its rising 50-day moving average, losing more than 4%, but bounced back into positive territory. Shares in the leader in cystic fibrosis treatments rallied more than 2% in volume running 16% above usual levels. Please go to IBD SwingTrader to see why it's creating a short-term trading opportunity in the stock market today. Other growth ... "], ["2020-05-27 15:40", "VRTX vs. ILMN: Which Stock Should Value Investors Buy Now? ... of the metrics contributing to VRTX's Value grade of B and ILMN's Value grade of D. VRTX stands above ILMN thanks to its solid earnings outlook, and based on these valuation figures, we also feel that VRTX is the superior value option right now. In-Depth Zacks Research for the Tickers Above Normally $25 each - click below to receive one report FREE: Vertex Pharmaceuticals Incorporated (VRTX) - free report > > Illumina, Inc. (ILMN) - free report > > Published in value-stocks which-stock-is-cheaper Zacks' 7 Best Strong Buy Stocks for June, 2020 Free Research for Zacks.com Readers Experts have chosen 7 stocks out of 220 Zacks Rank #1 Strong Buys that have the highest potential to increase in price quickly amid the global health crisis. A recent pick ... "], ["2020-05-27 15:30", "Has Vertex Pharmaceuticals (VRTX) Outpaced Other Medical Stocks This Year? ... VRTX's full-year earnings has moved 13.22% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger. Our latest available data shows that VRTX has returned about 21.72% since the start of the calendar year. Meanwhile, the Medical sector has returned an average of -2.18% on a year-to-date basis. This means that Vertex Pharmaceuticals is performing better than its sector in terms of year-to-date returns. Looking more specifically, VRTX belongs to the Medical - Biomedical and Genetics industry, which includes 382 individual stocks and currently sits at #21 in the Zacks Industry Rank. This group has gained an average of 6.51% so far this year, so VRTX is performing better in this area. Going forward, investors ... "], ["2020-05-27 13:15", "Profit From 5 Stocks Likely to Beat on Earnings ...  in East United States. The stock has a Zacks Rank #1. You can see the complete list of today's Zacks #1 Rank stocks here . Fortinet Inc. ( FTNT - Free Report ) : The Zacks Rank #2 provider of network security appliances comes from a favorable Zacks industry (placed at the top 22% of total 250+ industries in the Zacks universe). Vertex Pharmaceuticals Incorporated ( VRTX - Free Report ) : The company is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The stock hails from a favorable Zacks industry (top 6%) and has a Zacks Rank #1. SPS Commerce Inc. ( SPSC - Free Report ) : SPS Commerce is a provider of on-demand supply chain management solutions, providing integration, collaboration ... "], ["2020-05-27 11:15", "S&P Reclaims 3,000: Buy 6 Stocks With More Than 25% Growth ...  one of the world's largest producers of gold with several active mines in Nevada, Peru, Australia and Ghana. It has an estimated earnings growth of 82.6% for this year and a market cap of $50.6 billion. The stock has a Growth Score of B and falls under a top-ranked industry (placed at the top 8% of 250+ industries in the Zacks universe). Vertex Pharmaceuticals Incorporated ( VRTX - Free Report ) This Zacks Ranked #1 company is focused on the discovery, development and commercialization of small molecule drugs targeting serious diseases. It has an estimated earnings growth of 65.1% for this year and a market cap of $73.9 billion. The stock has a Growth Score of A and falls under the top-ranked industry ( top 6% ). BristolMyers Squibb Company ( BMY - Free ... "], ["2020-05-27 07:49", "Bizarre Stock Market Rally Leaves Wall Street's Best Billionaires Dumbfounded ...  of the stock market rally as his big bet on Hertz crumbled. U.S. stocks are continuing to climb, and ultra high net-worth investors are not re-entering the market. The U.S. stock market increased by 7.5% since May 13, within less than three weeks. Tech, biotech, and semiconductor led the market uptrend, as Apple, AMD, NVIDIA, Microsoft, Vertex Pharmaceuticals among other stocks outperformed expectations. The U.S. stock market continues its v-shape recovery | Source: Yahoo Finance Why Are Billionaires Cautious About the Stock Market? Since April, many billionaire investors and Wall Street barons were cautious about the U.S. stock market. The sentiment around stocks dropped due to a confluence of rising geopolitical risks, uncertainties around the pandemic ... "], ["2020-05-26 16:38", "IBD Live Q&A Summary, Key Lists For Tuesday, May 26, 2020 ...  Inc TMO Thermo Fisher Scientific TMUS T-Mobile U.S. Inc TNDM Tandem Diabetes Care Inc TPTX Turning Point Therap TREX Trex Company Inc TSLA Tesla Inc TTD The Trade Desk Inc Cl A TW Tradeweb Markets Cl A TWLO Twilio Inc Cl A TYL Tyler Technologies Inc UNH Unitedhealth Group Inc UNP Union Pacific Corp V Visa Inc Cl A VEEV Veeva Systems Inc Cl A VRTX Vertex Pharmaceuticals WING Wingstop Inc WIX Wix.com Ltd WORK Slack Technologies Cl A WPM Wheaton Precious Metals WST West Pharmaceutical Svcs Z Zillow Group Inc Cl C ZM Zoom Video Comm Cl A ZS Zscaler Inc Top Mutual Funds For Stock Research Symbol Name ALSAX ALGER SMALL CAP GROWTH A ACRNX Columbia Acorn Inst FCNTX Fidelity Contrafund FMAGX Fidelity Magellan FOCPX Fidelity OTC FKGRX Franklin Growth A VGRAX Invesco ... "], ["2020-05-26 12:17", "2 Top Factors Buoy Wall Street Since Memorial Day: 5 Picks ...  is 53.6% and 23.1%, respectively. For the next year, the company's expected earnings growth rate is 29.2%. Moderna develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases. The company currently has a Zacks Rank #2. The company's expected earnings growth rate for the next five-year period is 33.6%. Vertex Pharmaceuticals Incorporated ( VRTX - Free Report ) , known for developing and commercializing therapies for treating cystic fibrosis, has provided $500,000 to Partners HealthCare to enhance testing capacity vital to limiting the spread of this virus. The company currently has a Zacks Rank #1. The company's expected earnings growth rate for the current quarter and year is 65.9% and 65.1%, respectively ... "], ["2020-05-24 18:04", "Is Vertex Pharmaceuticals Stock a Buy? ... , radio show, and premium investing services. Who Is the Motley Fool? About Us Reviews Foolanthropy Media Inquiries Contact Us Fool Podcasts Motley Fool Money Marketfoolery Industry Focus Motley Fool Answers Rule Breaker Investing Social Media + Facebook Twitter YouTube Discussion Boards CAPS - Stock Picking Community New Ventures The Ascent Millionacres The Blueprint Soapbox Search Search: Is Vertex Pharmaceuticals Stock a Buy? This successful biotech has two big things going for it. Keith Speights (TMFFishBiz) May 24, 2020 at 2:04PM Author Bio Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical ... "], ["2020-05-24 13:02", "If You'd Invested $10,000 in Moderna's IPO, Here's How Much Money You'd Have Now ...  415% 87% Stock Advisor launched in February of 2002. Returns as of 05/24/2020. Join Stock Advisor Cumulative Growth of a $10,000 Investment in Stock Advisor Calculated by Time-Weighted Return Stocks MRNA Moderna INC NASDAQ: MRNA $67.05 down $-6.42 (-8.74%) MRK Merck & Co. NYSE: MRK $76.55 down $0.34 (-0.44%) AZN AstraZeneca NYSE: AZN $55.28 up $1.50 (2.79%) VRTX Vertex Pharmaceuticals NASDAQ: VRTX $284.63 up $0.01 (0.00%) Related Articles Can Moderna Win the Race to Find a COVID-19 Vaccine? Moderna Shares Up Almost 250% This Year as Vaccine Trials Continue Moderna Shares Surged 20% on Coronavirus Vaccine Data. Here's What May Drive Them Higher. Why Moderna Stock Dropped Thursday Will Moderna Stock Surge to $90? If You'd Invested $10,000 in Moderna ... "], ["2020-05-24 11:35", "Here's Why You Might Not Want to Buy Stocks Right Now ...  happens next. Motley Fool Returns Stock Advisor S&P 500 415% 87% Stock Advisor launched in February of 2002. Returns as of 05/24/2020. Join Stock Advisor Cumulative Growth of a $10,000 Investment in Stock Advisor Calculated by Time-Weighted Return Stocks AAPL Apple NASDAQ: AAPL $316.85 down $-2.38 (-0.75%) CVS CVS Health NYSE: CVS $63.34 up $0.12 (0.19%) VRTX Vertex Pharmaceuticals NASDAQ: VRTX $284.63 up $0.01 (0.00%) Related Articles 3 Warren Buffett Stocks to Buy Right Now 3 Warren Buffett Stocks Worth Buying Now Surprise! Most FAANG Stocks Are Historically Cheap 3 Warren Buffett Dividend Stocks That You Can Buy Right Now 3 of the Safest Dividend Stocks in the World Here's Why You Might Not Want to Buy Stocks Right Now @themotleyfool #stocks $AAPL ... "]]}}